Trial Profile
A Phase I Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs KDT 3594 (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Kissei Pharmaceutical
- 29 Mar 2019 Status changed from active, no longer recruiting to completed.
- 05 Dec 2018 Planned primary completion date changed from 1 Jan 2018 to 1 Jan 2019.
- 05 Dec 2018 Status changed from recruiting to active, no longer recruiting.